Alvarez-Torres, Maria del Mar; Balaña, Carmen; Fuster García, Elíes; Puig, Josep; Garcia-Gomez, Juan M(MDPI AG, 2024-01)
[EN] Background: Aberrant vascular architecture and angiogenesis are hallmarks of glioblastoma IDH-wildtype, suggesting that these tumors are suitable for antiangiogenic therapy. Bevacizumab was FDA-approved in 2009 following ...